Fresh IPO Signals: Director Buys PBLS Stock—What It Means
A Parabilis Medicines director recently disclosed a substantial stake just after the company’s fresh IPO. This articl...
Determine whether a 6-month or 12-month fund is right for you by assessing income stability, essential expenses, and personal risk appetite.
15,911 articlesA Parabilis Medicines director recently disclosed a substantial stake just after the company’s fresh IPO. This articl...
When Intuitive Machines announced a major equity raise, the stock sold off hard. But a disciplined look shows the mov...
Keir Starmer announces resignation with a September deadline for a new prime minister, triggering volatility in UK ma...
Bitcoin edged above $65,000 as oil prices slipped, but traders warn that stubborn dollar strength and elevated yields...
Want to know if Bristol Myers Squibb is worth a spot in your portfolio? This deep dive highlights three core reasons ...
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Spotify faces a pivotal 2026-2028 window as earnings beat meet guarded guidance. This piece breaks down where Spotify...
Senate lawmakers move to investigate a UAE-backed investment in a Trump-linked crypto venture, signaling a potential ...
A brutal courier-fraud scheme targeted older adults, draining about £130,000 from 85 victims. Three men have been jai...
As discounts surge through the warm months, shoppers and investors gain a rare window to save on essentials and stake...
Bitcoin’s bear market struggle is driving layoffs and automation in crypto firms even as banks and fintechs chase big...
Investors are watching a rising probability federal reserve rate move, a signal that everyday market dynamics could s...